Galmed Pharmaceuticals Ltd

Quick facts

Phase 3 pipeline

• Aramchol free acid · Hepatology
  Aramchol inhibits stearoyl-CoA desaturase 1 (SCD1), an enzyme that converts saturated fatty acids to monounsaturated fatty acids, thereby reducing hepatic lipogenesis and improving liver metabolism.

Phase 2 pipeline

• Aramchol · Other

Phase 1 pipeline

• amilo-5MER

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Galmed Pharmaceuticals Ltd portfolio CI brief
• Galmed Pharmaceuticals Ltd pipeline updates RSS